Stratified control of IGF-I expression by hypoxia and stress hormones in osteoblasts

被引:11
作者
McCarthy, Thomas L. [1 ,2 ]
Yun, Zhong [3 ]
Madri, Joseph A. [2 ]
Centrella, Michael [1 ,2 ]
机构
[1] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA
关键词
PGE2; Glucocorticoid; HIF; C/EBP; Runx2; GROWTH-FACTOR-I; BINDING PROTEIN-DELTA; INDUCIBLE FACTOR-1-ALPHA PATHWAY; RUNX TRANSCRIPTION FACTORS; OXYGEN-TENSION; FACTOR-BETA; GENE-EXPRESSION; RECEPTOR EXPRESSION; CELL-PROLIFERATION; SIGNALING PATHWAY;
D O I
10.1016/j.gene.2014.01.011
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Bone cells respond to the integrated effects of local and systemic regulation. Here we show that hypoxia and the stress hormones PGE2 and glucocorticoid interact in complex ways in osteoblasts, converging on insulin like growth factor I (IGF-I) expression. Whereas hypoxia alone rapidly increased transcription factor HIF activity, it suppressed DNA synthesis, had no significant effects on protein synthesis or alkaline phosphatase activity, and drove discrete changes in a panel of osteoblast mRNAs. Notably, hypoxia increased expression of the acute phase response transcription factor C/EBP delta which can induce IGF-I in response to PGE2, but conversely prevented the stimulatory effect of PGE2 on IGF-I mRNA. However, unlike its effect on C/EBP delta, hypoxia suppressed expression of the obligate osteoblast transcription factor Runx2, which can activate an upstream response element in the IGF-I gene promoter. Hypoxic inhibition of IGF-I and Runx2 were enforced by glucocorticoid, and continued with prolonged exposure. Our studies thus reveal that IGF-I expression is stratified by two critical transcriptional elements in osteoblasts, which are resolved by the individual and combined effects of hypoxic stress and stress hormones. In so doing, hypoxia suppresses Runx2, limits the enhancing influence of PGE2, and interacts with glucocorticoid to reduce IGF-I expression by osteoblasts. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:141 / 151
页数:11
相关论文
共 98 条
  • [41] Repetitive exposure to TGF-β suppresses TGF-β type I receptor expression by differentiated osteoblasts
    Kim, Kenneth K.
    Ji, Changhua
    Chang, Weizhong
    Wells, Rebecca G.
    Gundberg, Caren M.
    McCarthy, Thomas L.
    Centrella, Michael
    [J]. GENE, 2006, 379 : 175 - 184
  • [42] Role of the glucocorticoid receptor for regulation of hypoxia-dependent gene expression
    Kodama, T
    Shimizu, N
    Yoshikawa, N
    Makino, Y
    Ouchida, R
    Okamoto, K
    Hisada, T
    Nakamura, H
    Morimoto, C
    Tanaka, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (35) : 33384 - 33391
  • [43] Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control
    Koritzinsky, M
    Magagnin, MG
    van den Beucken, T
    Seigneuric, R
    Savelkouls, K
    Dostie, J
    Pyronnet, S
    Kaufman, RJ
    Weppler, SA
    Voncken, JW
    Lambin, P
    Koumenis, C
    Sonenberg, N
    Wouters, BG
    [J]. EMBO JOURNAL, 2006, 25 (05) : 1114 - 1125
  • [44] Translating tumor hypoxia: Unfolded protein response (UPR)-dependent and UPR-independent pathways
    Koumenis, Constantinos
    Wouters, Bradly G.
    [J]. MOLECULAR CANCER RESEARCH, 2006, 4 (07) : 423 - 436
  • [45] Hypoxia regulates PGE2 release and EN receptor expression in osteoblastic cells
    Lee, Christina M.
    Genetos, Damian C.
    You, Zongbing
    Yellowley, Clare E.
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 212 (01) : 182 - 188
  • [46] Prostaglandin expression profile in hypoxic osteoblastic cells
    Lee, Christina M.
    Genetos, Damian C.
    Wong, Alice
    Yellowley, Clare E.
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2010, 28 (01) : 8 - 16
  • [47] Lee H., 2013, AM J RESP CELL MOL B
  • [48] Differential Hypoxic Regulation of Hypoxia-Inducible Factors 1α and 2α
    Lin, Qun
    Cong, Xiangyu
    Yun, Zhong
    [J]. MOLECULAR CANCER RESEARCH, 2011, 9 (06) : 757 - 765
  • [49] Madri JA, 2009, J PHYSIOL PHARMACOL, V60, P95
  • [50] Emerging Treatments for Retinopathy of Prematurity
    Mantagos, Iason S.
    Vanderveen, Deborah K.
    Smith, Lois E. H.
    [J]. SEMINARS IN OPHTHALMOLOGY, 2009, 24 (02) : 82 - 86